Article Details
Retrieved on: 2024-03-24 14:23:17
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Bharat Biotech's initiation of MTBVAC Tuberculosis vaccine trials in India, which could improve protection beyond the traditional BCG vaccine against the global health threat posed by Mycobacterium tuberculosis.
Article found on: www.newsx.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here